# Stryker invests $400M in CMR Surgical with option to acquire

Stryker announced a strategic alliance with CMR Surgical, including an approximately $400 million preferred equity investment and an exclusive option to acquire 100% of CMR Surgical. Stryker will serve as the exclusive U.S. sales agent for the Versius portfolio.

- Type: Partnership
- Announced: 2018-05-25
- Where: United States
- Value: $400.0M
- Status: announced
- Products: Versius Surgical Robotic portfolio
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Automation and Robotics](https://endata.com/sectors/automation-robotics.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md) (investor)
- [CMR Surgical](https://endata.com/companies/15356.md) (partner)

## Sources

- [business.sherbrookerecord.com](https://business.sherbrookerecord.com/sherbrookerecord/article/gnwcq-2026-10-12-stryker-and-cmr-surgical-announce-strategic-alliance-to-advance-robotic-assisted-surgery), 2018-05-25: "Strategic alliance combines CMR Surgical’s established platform and robotics expertise with Stryker’s scale, customer relationships and commercial reach to accelerate growth of the Versius Surgical Robotic portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.